FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF1 agonist mediated visceral hypersensitivity in male rats

By sjmartinez • October 1, 2024

Larauche M, Mulak A, Ha C, Million M, Arnett S, Germano P, Pearson JP, Currie MG, Taché Y. FAAH inhibitor URB597 shows anti-hyperalgesic action and increases brain and intestinal tissues fatty acid amides in a model of CRF₁ agonist mediated visceral hypersensitivity in male rats. Neurogastroenterol Motil. 2024 Sep 30:e14927. doi: 10.1111/nmo.14927. Epub ahead of print. PMID: 39344695.

Tags: anandamide, cortagine, defecation, Digestive Diseases, Irritable Bowel Syndrome, Publications, rat, URB597, Veterans Administration, Visceral pain

One in 4 transplant hepatologists in the United States screens positive for unhealthy alcohol use

Coe C, Prause N, Benhammou JN, Singh J, Shetty A, Trivedi HD, Yanny B, Shoptaw S, Pourmand K, Patel AA. One in 4 transplant hepatologists[...]

Physical activity and advanced fibrosis in MASLD, MetALD, and ALD in a nationally representative cohort: NHANES 2017-2020

Dunn N, Zhang W, Blaney HL, Diaz LA, Patel A, Wong RJ, Arab JP, Younossi Z, McClain C, Kong M, Singal AK. Physical activity and[...]

Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable Bowel Syndrome

Shin A, Xu H, Sarnoff R, Church A, Chang L. Research Communication: An Observational Cohort Study on Risk of Ovarian Cancer in Women with Irritable[...]